| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |